v3.25.2
Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Statement of Cash Flows [Abstract]    
Net income $ 150,785 $ 815,722
Adjustments to reconcile net income to net cash (used in) provided by operating activities:    
Depreciation 314,344 353,586
Amortization 47,914 48,476
Credit loss (recovery) 4,818 (567,384)
Deferred tax (benefits) expenses (85,255) 24,805
Gains on disposal of fixed assets (1,448)
Foreign currency transaction (gains) loss (235,965) (29,409)
Changes in operating assets and liabilities:    
Accounts receivable 444,870 5,222,075
Notes receivable (71,521) (1,287,936)
Inventories (5,236,578) (1,967,053)
Advances to suppliers (1,175,868) (703,267)
Advances to suppliers – related parties 671,612 (1,010,512)
Other receivables (499,423) (382,670)
Other noncurrent assets 19,628 (742)
Accounts payable (1,050,993) (2,095,988)
Accounts payable - related parties (3,738,303)
Accrued expenses and other current liabilities (113,772) (354,407)
Notes payable (4,439,896) 3,167,373
Advances from customers 1,102,089 (883,933)
Advances from customers – related parties 15,207 (1,008,232)
Taxes payable (759,942) (1,065,494)
Net cash used in operating activities (10,899,394) (5,463,293)
Cash Flows from Investing Activities:    
Purchases of property, plant and equipment (75,244) (81,163)
Proceeds from disposition of property, plant and equipment 14,686
Acquisition of CIP (2,954,766)
Net cash used in investing activities (3,015,324) (81,163)
Cash Flows from Financing Activities:    
Proceeds from short-term borrowings 2,501,762 2,499,324
Repayments on short-term borrowings (1,212,915) (4,498,110)
Proceeds from long-term borrowings 2,765,946 2,761,434
Repayments on long-term borrowings (6,495,615)
Proceeds from share issuance, net of offering costs
Repayments to related parties (48,404) (20,815)
Net cash provided by (used in) financing activities 4,006,389 (5,753,782)
Effect of exchange rate changes on cash and cash equivalents and restricted cash (469,071) (62,912)
Net (decrease) increase in cash and cash equivalents and restricted cash (10,377,400) (11,361,150)
Cash and cash equivalents and restricted cash at the beginning of period 22,528,945 20,961,693
Cash and cash equivalents and restricted cash at the end of period 12,151,545 9,600,543
Reconciliation of cash and cash equivalents and restricted cash to the Consolidated Balance Sheet    
Cash and cash equivalents 9,205,552 7,803,550
Restricted cash 2,945,993 1,796,993
Total cash and cash equivalents and restricted cash at the end of period 12,151,545 9,600,543
Supplemental disclosures of cash flows information:    
Cash paid for income taxes 340,560 362,992
Cash paid for interest $ 53,631 $ 90,630